user1.arrisa.xyz Open in urlscan Pro
217.144.98.187  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * Careers
 * Contact Us
 * Donate
 * Subscribe


 * Home
 * About
   * About
   * Board of Directors
   * Senior Leadership
   * Financial Statements
   * Global Funding & Support
   * Our History: 1995-2021
 * Our Work
   * Our Work
   * Discovery & Research
     * Antibody Translational Research Program
     * Human Immunology Laboratory
     * IAVI Neutralizing Antibody Center
     * Vaccine Design and Development Laboratory
     * Clinical Research Centers
     * Clinical Research Standards
     * Observational Epidemiology Studies
     * IAVI in Africa
   * Translation & Product Development
   * Global Access to Scientific Innovations
   * ADVANCE
     * IAVI DataSpace
   * Advocacy & Community Engagement
     * CASPR
     * Tuberculosis R&D Advocacy
     * World Bank/Japan-supported
       Partnerships | 日本政府・世銀が支援するパートナーシップ
 * Our Science
   * Our Science
   * Pipeline
   * HIV Vaccines
   * bnAbs for HIV Prevention
   * Tuberculosis Vaccines
   * Emerging Infectious Diseases Vaccines
 * News & Resources
   * Latest News
   * Scientific Publications
   * Press Releases
   * Features
   * IAVI Report
   * IAVI in the News
   * Fact Sheets & Publications
   * Vaccine Literacy Library
   * VOICES Newsletter
   * Multimedia
   * Media Contacts
   * Subscribe


 * Careers
 * Contact Us
 * Donate
 * Subscribe



Toggle navigation
 * Decrease font size Increase font size Default font sizes
 * Bright contrast Dark contrast Grayscale Reset contrast
 * Keyboard Navigation
 * Toggle underline

 * Home
 * About
   * About
   * Board of Directors
   * Senior Leadership
   * Financial Statements
   * Global Funding & Support
   * Our History: 1995-2021
 * Our Work
   * Our Work
   * Discovery & Research
   * Translation & Product Development
   * Global Access to Scientific Innovations
   * ADVANCE
   * Advocacy & Community Engagement
 * Our Science
   * Our Science
   * Pipeline
   * HIV Vaccines
   * bnAbs for HIV Prevention
   * Tuberculosis Vaccines
   * Emerging Infectious Diseases Vaccines
 * News & Resources
   * Latest News
   * Scientific Publications
   * Press Releases
   * Features
   * IAVI Report
   * IAVI in the News
   * Fact Sheets & Publications
   * Vaccine Literacy Library
   * VOICES Newsletter
   * Multimedia
   * Media Contacts
   * Subscribe

 * Translating scientific discoveries
   into affordable, globally accessible
   public health solutions
 * Translating scientific discoveries
   into affordable, globally accessible
   public health solutions
 * Translating scientific discoveries
   into affordable, globally accessible
   public health solutions
 * Translating scientific discoveries
   into affordable, globally accessible
   public health solutions
 * Translating scientific discoveries
   into affordable, globally accessible
   public health solutions
 * Translating scientific discoveries
   into affordable, globally accessible
   public health solutions


 * 
 * 
 * 
 * 
 * 
 * 

 * 
 * 
 * 
 * 
 * 
 * 

LATEST NEWS

ZENDAL AND IAVI ANNOUNCE EXPANDED AGREEMENT ON DEVELOPMENT OF MTBVAC

IAVI PAPER ON STRENGTHENING PATHWAYS TO ACCELERATE GLOBAL ACCESS TO MABS

IAVI REPORT: A VIEW FROM ZAMBIA ON HIV VACCINE RESEARCH

IAVI REPORT: IMPROVING ACCESS TO VACCINES

DANISH GOVERNMENT RENEWS SUPPORT FOR IAVI'S HIV PREVENTION PROGRAM

MEET THE SCIENTIST ON THE CUSP OF DEVELOPING A NOVEL HIV VACCINE CANDIDATE

WHAT WE DO

WHAT WE DO

DISCOVER

new approaches to developing vaccines and antibodies for HIV, TB, emerging
infectious diseases, and neglected diseases.

ACCELERATE

translational and clinical research through our laboratories in the U.S., India,
and the U.K.

BUILD CAPACITY

in-country for researching vaccine candidates while strengthening local public
health and scientific expertise.

PARTNER

with industry and enlist biopharma product development skills to develop
innovative products tailored to target populations.

SHARE

IAVI’s resources with other innovators to help the global health community as a
whole succeed.

EXTEND

IAVI’s core capabilities to solving disease prevention and treatment challenges.





ABOUT

About

Board of Directors

Senior Leadership

Financial Statements

Global Funding & Support

Our History: 1995-2021

OUR WORK

Our Work

Discovery & Research

Translation & Product Development

Global Access to Scientific Innovations

ADVANCE

Advocacy & Community Engagement

OUR SCIENCE

Our Science

Pipeline

HIV Vaccines

bnAbs for HIV Prevention

Tuberculosis Vaccines

Emerging Infectious Diseases Vaccines

NEWS & RESOURCES

Latest News

Scientific Publications

Press Releases

Features

IAVI Report

IAVI in the News

Fact Sheets & Publications

Vaccine Literacy Library

VOICES Newsletter

Multimedia

Media Contacts

Subscribe

Accessibility

Compliance/RFPs

Contact IAVI

Privacy Policy

Site Map

Supplier Diversity

Terms of Use

©2023 International AIDS Vaccine Initiative. International AIDS Vaccine
Initiative®, IAVI®, and the IAVI logo® are registered trademarks of the
International AIDS Vaccine Initiative, Inc.


×


DON’T MISS A THING

Sign up to receive updates on IAVI‘s work
and the latest news from the field

SUBSCRIBE NOW